Skip to main content

Conclusions, Perspectives, and Future Considerations

  • Chapter
  • First Online:
  • 1961 Accesses

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Abstract

As a result of the AYA age range adopted by the US National Cancer Institute Progress Review Group, the authors of this second edition have risen to the challenge of extending the upper age limit from 29 to 39 years. This has uncovered some unanticipated revelations, especially in the realms of epidemiology and biology. For example, in the former, a remarkable and hitherto unknown incidence of prostate cancer in young adults has come to light, while in the latter, the age-related trajectory of characteristics that typify cancers in the AYA population has been expanded to bridge the gap between adolescents and older adults, as in acute lymphoblastic leukemia (ALL) and colorectal cancers. Another important finding is the overdiagnosis of some cancers in AYAs, as best evidenced by renal and thyroid carcinomas. These data have been amplified in the chapters on individual diseases.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Albritton K, Barr R, Bleyer A (2010) The adolescence of young adult oncology. Semin Oncol 36:478–488

    Article  Google Scholar 

  2. Pui C-H, Yang JJ, Hunger SP et al (2015) Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol 33:2938–2948

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Freyer DR, Seibel NL (in press) The clinical trials gap for adolescents and young adults with cancer: recent progress and conceptual framework for continued research. Curr Pediatr Rep. doi:10.1007s40124-0075-y

    Google Scholar 

  4. Fern LA, Lewandowski JA, Coxon KM et al (2014) Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials. Lancet Oncol 15:e341–e350

    Article  PubMed  Google Scholar 

  5. Weiss AR, Nichols CR, Freyer DR (2015) Enhancing adolescent and young adult oncology research within the National Clinical Trials Network: rationale, progress and emerging strategies. Semin Oncol 42:740–747

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wilkins KL, D’Agostino N, Penney AM, Barr RD, Nathan PC (2014) Supporting adolescents and young adults with cancer through transitions: position statement from the Canadian Task Force on adolescents and young adults with cancer. J Pediatr Hematol Oncol 36:545–551

    Article  PubMed  Google Scholar 

  7. Woodruff TK (2007) The emergence of a new interdiscipline: oncofertility. Cancer Treat Rep 138:3–11

    Article  Google Scholar 

  8. Yabroff KR, Dowling EC, Guy GP Jr et al (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. Pii; JCO620468 34:259–267

    Google Scholar 

  9. Light DW, Kantarjian H (2013) Market spiral pricing of cancer drugs. Cancer 119:3900–3902

    Article  PubMed  Google Scholar 

  10. Conti RM, Padula WV, Larson RA (2015) Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU. Ann Hematol 94(Suppl 2):S249–S257

    Article  PubMed  PubMed Central  Google Scholar 

  11. LaMontagne C (2015) NerdWallet Health finds medical bankruptcy accounts for majority of personal bankruptcies. http://www.nerdwallet.com/blog/health/medical-bills/nerdwallet-health-study-estimates-56-million-americans-65-struggle-medical-bills-2013. Accessed 29 Dec 2015

  12. Tefferi A, Kantarjian H, Rajkumar SV et al (2015) In support of a patient-driven initiative and petition to lower the high price of cancer drugs. Mayo Clin Proc 90:996–1000

    Article  PubMed  PubMed Central  Google Scholar 

  13. Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A (2007) Delays in cancer diagnosis in under-insured young adults and older adolescents. Oncologist 12:816–824

    Article  PubMed  Google Scholar 

  14. Wessler JM, Crouch G, Bleyer A, Merino M (2010) Lagtime to oncologic diagnoses: a comparison between military and non-military health care systems. Pediatr Blood Cancer 54: Abstr 195

    Google Scholar 

  15. Robbins AS, Lerro CC, Barr RD (2014) Insurance status and distant-stage disease among adolescent and young adult patients with cancer aged 15–39 years. National Cancer Database, 2004 through 2010. Cancer 120:1212–1219

    Article  PubMed  Google Scholar 

  16. Bleyer A, Ulrich C, Martin S (2012) Young adults, cancer, health insurance, socioeconomic status and the Patient Protection and Affordable Care Act. Cancer 118:6018–6021

    Article  PubMed  Google Scholar 

  17. Zebrack BJ, Corbett V, Embry L et al (2014) Psychological distress and unsatisfied need for psychosocial support in adolescent and young adult cancer patients during the first year following diagnosis. Psychooncology 23:1267–1275

    Article  PubMed  Google Scholar 

  18. Zebrack BJ, Block R, Hayes-Lattin B et al (2013) Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients. Cancer 119:201–214

    Article  PubMed  Google Scholar 

  19. Recklitis CJ, Blackmon JE, Chang G (2016) Screening young adult cancer survivors for distress with the distress thermometer: comparisons with a structured clinical diagnostic interview. Cancer 122:296–303

    Google Scholar 

  20. Bhatia S, Landier W, Shangguan M et al (2012) Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia. A report from the Children’s Oncology Group. J Clin Oncol 30:2094–2101

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ganesan P, Sagar TG, Dubashi B et al (2011) Nonadherence to imatinib adversely affects event-free survival in chronic phase chronic myeloid leukemia. Am J Hematol 86:471–474

    Article  PubMed  Google Scholar 

  22. Kremelke K, Juergens C, Alz H, Reinhardt D (2015) Patients’ adherence in the maintenance therapy of children and adolescents with acute lymphoblastic leukemia. Klin Padiatr 227:326–334

    Google Scholar 

  23. Landier W, Chen Y, Hageman L et al (2015) 6-Mercaptopurine intake during maintenance for childhood acute lymphoblastic leukemia – a comparison of self-report and electronic monitoring. A report from the Children’s Oncology Group study AALL03N1. Ann Manag Am Soc Hematol Abstr 82

    Google Scholar 

  24. Anderson KR, Chambers CR, Lam N et al (2015) Medication adherence among adults prescribed dasatinib or nilotinib for the treatment of chronic myeloid leukemia. J Oncol Pharm Pract 21:19–25

    Article  PubMed  Google Scholar 

  25. Osborn M, Little C, Bowering S, Orme L (2013) Youth cancer services in Australia. Development and implementation. J Adolesc Young Adult Oncol 2:118–124

    Article  PubMed  Google Scholar 

  26. Fern L, Whelan J (2013) National Cancer Research Institute Teenage and Young Adult Clinical Studies Group: the United Kingdom approach to research. J Adolesc Young Adult Oncol 2:161–165

    Article  PubMed  Google Scholar 

  27. Johnson RH (2013) AYA in the USA. J Adolesc Young Adult Oncol 2:167–174

    Article  PubMed  PubMed Central  Google Scholar 

  28. Zebrack B, Mathews-Bradshaw B, Siegel S (2010) Quality cancer care for adolescents and young adults: a position statement. J Clin Oncol 28:4862–4867

    Article  PubMed  Google Scholar 

  29. Hayes-Lattin B, Mathews-Bradshaw B, Siegel S (2010) Adolescent and young adult oncology training for health professionals: a position statement. J Clin Oncol 28:4858–4861

    Article  PubMed  Google Scholar 

  30. Nass SJ, Beaupin LJ, Demark-Wahnefried W et al (2015) Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist 20:186–195

    Article  PubMed  PubMed Central  Google Scholar 

  31. Keegan THM, Lichtensztajn DY, Kato I et al (2012) Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv 6:239–250

    Article  PubMed  PubMed Central  Google Scholar 

  32. Tai E, Buchanan N, Townsend J et al (2012) Health status of adolescent and young adult cancer survivors. Cancer 118:4884–4891

    Article  PubMed  PubMed Central  Google Scholar 

  33. Guy GP Jr, Ekwueme DU, Yabroff KR et al (2013) Economic burden of cancer survivorship among adults in the United States. J Clin Oncol 31:3749–3757

    Article  PubMed  PubMed Central  Google Scholar 

  34. Barr RD, Holowaty EJ, Birch JM (2006) Classification schemes for tumors diagnosed in adolescents and young adults. Cancer 106:1425–1430

    Article  PubMed  Google Scholar 

  35. Barr RD, Ferrari A, Ries L, Whelan J, Bleyer WA (2016) A narrative review of cancer in adolescents and young adults. Current status and a view of the future. JAMA Pediatr 170;495–501

    Google Scholar 

  36. Institute for Health Metrics and Evaluation (IHME) (2015) GBD compare. IHME, University of Washington, Seattle, Available from http://vizhub.healthdata.org/gbd-compare. Accessed 20 Jan 2016

    Google Scholar 

  37. Ferrari A, Thomas D, Franklin ARK et al (2010) Starting an adolescent and young adult program: some success stories and some obstacles to overcome. J Clin Oncol 28:4850–4857

    Article  PubMed  Google Scholar 

  38. Barr RD, Ries LAG, Lewis DR, Harlan LC, Keegan THM, Pollock BR, Bleyer A, for the U.S. National Cancer Institute Next Steps for Adolescent and Young Adult Oncology Epidemiology Working Group (2016) U.S. incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “non-malignant” tumors. Cancer 122;1000–1008

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronald D. Barr .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing

About this chapter

Cite this chapter

Barr, R.D., Ries, L., Ferrari, A., Whelan, J., Bleyer, A. (2017). Conclusions, Perspectives, and Future Considerations. In: Bleyer, A., Barr, R., Ries, L., Whelan, J., Ferrari, A. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-33679-4_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33679-4_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33677-0

  • Online ISBN: 978-3-319-33679-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics